查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
失眠全球市場規模、份額和行業趨勢分析報告：按分銷渠道（醫院、零售、其他）、治療類型（藥物、非藥物）、區域展望和預測2022-2028
市場調查報告書
商品編碼
1150349

失眠全球市場規模、份額和行業趨勢分析報告：按分銷渠道（醫院、零售、其他）、治療類型（藥物、非藥物）、區域展望和預測2022-2028

Global Insomnia Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Hospital, Retail, and Others), By Therapy Type (Pharmacological and Non-Pharmacological), By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 149 Pages | 訂單完成後即時交付

價格

在預測期內，全球失眠市場規模預計將以 3.9% 的複合年增長率增長，到 2028 年將達到 57 億美元。

由於工作相關壓力的增加，失眠市場正在增長。增加的工作量和苛刻的工作時間表會導致睡眠不足。此外，包括保安人員在內的許多人都在不定期輪班工作，並且生產全天候開放。這些不規律的輪班會影響睡眠的質量和節奏。近年來，睡眠診斷和失眠症中心的數量也有所增加。失眠中心幫助人們獲得更好的睡眠質量，睡眠障礙中心充當診斷實驗室。

COVID-19 影響分析

COVID-19的爆發有望利好失眠藥物的市場拓展。 Covid-19 大流行使行業陷入癱瘓，使許多工人失業，並加劇了社會壓力水平。其他人則因害怕大流行病而患上抑鬱症。因此，預計 COVID-19 大流行將增加因壓力和抑鬱引起的失眠的發生率，增加對失眠藥物的需求並擴大市場。

市場增長因素

人口老齡化加劇

研究表明，老年人（65 歲以上）患某些類型癌症的可能性是年輕人的 11 倍。未來 20 年，隨著世界人口老齡化，老年人的癌症發病率預計會增加。屈光不正、白內障、睡眠問題和聽力損失在老年人中都很常見。在全球範圍內，許多老年人都有睡眠問題。因此，預計人口老齡化將導致失眠病例數量增加，進一步推動預測期內失眠市場的增長。

不斷上漲的醫療費用

由於對治療方案的認識提高，醫療保健成本上升和疾病的早期診斷預計將成為預測期內推動市場增長的因素。政府在醫療保健行業投資的規模和數量不斷增加也是推動市場增長的關鍵因素之一。隨著 COVID-19 大流行的開始，許多政府加大了對建設醫療保健系統的投資。隨著大流行的影響減弱，各家醫院都將這些資源集中在治療其他嚴重疾病上。由於醫療保健投資的增加，失眠市場正在增長。

市場製約因素

診斷和治療失眠的費用

診斷和治療失眠症的高成本是阻礙失眠症市場增長的主要因素之一。 “睡眠障礙”一詞還包括一系列對個人健康有重大負面影響並產生高社會成本的疾病。失眠使人難以過上正常的生活，經濟和醫療負擔也很大，許多患者甚至會完全殘疾。失眠患者每年直接在醫療保健上的花費是無症狀對照組的兩倍左右。由於藥價高，失眠市場沒有增長。

按分銷渠道劃分的前景

失眠藥物市場按分銷渠道分為醫院、零售和其他。 2021 年，零售部門在失眠市場的銷售額中佔據了相當大的份額。由於各種零售店廣泛供應睡眠障礙治療藥，這一領域的市場正在增長。此外，人們對失眠等疾病後果的認識不斷提高，也推動了這一市場的發展。政府還支持在這些商店出售的安眠藥。

治療類型的前景

根據治療類型，失眠市場分為非藥物療法和藥物療法。 2021年，藥物治療板塊主導失眠市場，收入佔比最大。這是由於失眠症患病率的上升以及失眠藥物的主要製造商數量的增加。失眠藥物和安眠藥的存在正在全世界蔓延。在這個領域，由於世界各地有許多市場參與者，市場規模正在增長。

區域概覽

按地區分析了北美、歐洲、亞太地區和 LAMEA 的失眠市場。 2021 年，北美地區在失眠市場的收入份額最高。這是由於醫療保健系統的發展，包括失眠症患病率增加、工作壓力大以及該地區失眠中心的存在。慢性腎病患者數量的增加以及該地區大量失眠診所的存在預計也將推動市場增長。

內容

第一章市場範圍與研究方法

  • 市場定義
  • 目的
  • 市場規模
  • 細分
    • 全球失眠市場，按分銷渠道
    • 全球失眠市場，按治療類型
    • 全球失眠市場，按地區
  • 調查方法

第 2 章市場概述

  • 簡介
    • 概覽
      • 市場構成和情景
  • 影響市場的主要因素
    • 市場驅動因素
    • 市場製約因素

第 3 章失眠市場部署的策略

第 4 章全球失眠市場：按分銷渠道

  • 全球醫院市場：按地區
  • 全球零售市場：按地區
  • 全球各地區的其他市場

第 5 章全球失眠市場：按治療類型分類

  • 全球藥物治療市場：按地區
  • 全球非藥物療法市場：按地區

第 6 章全球失眠市場：按地區

  • 北美
    • 按國家/地區劃分的北美失眠市場
      • 美國
      • 加拿大
      • 墨西哥
      • 北美以外的地區
  • 歐洲
    • 歐洲失眠市場：按國家/地區分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 其他歐洲
  • 亞太地區
    • 按國家/地區劃分的亞太地區失眠市場
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • 拉美
    • LAMEA 失眠症市場：按國家/地區分類
      • 巴西
      • 阿根廷
      • 阿聯酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • 其他拉美地區

第七章公司簡介

  • Eisai Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Vanda Pharmaceuticals, Inc.
  • Cadila Healthcare Ltd.（Zydus Cadila）
  • Sanofi S.A
  • Merck Group
  • Pfizer, Inc.
  • Viatris, Inc.
  • Currax Pharmaceuticals LLC（Currax Holdings USA LLC）
  • Purdue Pharma L.P

The Global Insomnia Market size is expected to reach $5.7 billion by 2028, rising at a market growth of 3.9% CAGR during the forecast period.

A common sleep disorder called insomnia can make it difficult to fall asleep, stay asleep, or wake up early and have trouble falling back asleep. Stress, bad sleeping habits, irregular sleep schedules, mental health conditions like physical illnesses and pain, anxiety and depression, medications, neurological issues, and specific sleep disorders are some of the common causes of insomnia.

The rise in the prevalence of distinct sleep disorders, including parasomnias as well as insomnia, and the rise in mental depression and other painful conditions, are the main factors driving the growth of the insomnia market size. Sleep issues are a result of mental depression. As a result, an increase in mental depression among the general population contributes to the growth of the insomnia market. Furthermore, taking some medications for a chronic condition over an extended period of time has some side effects that are thought to impair a patient's ability to sleep.

Additionally, the market for insomnia is expanding due to an increase in work-related stress. The increased workload and demanding work schedules result in poor sleep. Additionally, a lot of people including security guards work odd shifts, and the manufacturing sector is open around-the-clock. The quality and rhythm of sleep are impacted by these irregular work shifts. Also, a rise in the number of sleep diagnostics and centres for people with insomnia helps has been seen in the past few years. The centres for insomnia help people get better quality sleep, and the centres for sleep disorders are utilized as diagnostic testing facilities.

COVID-19 Impact Analysis

It is anticipated that the COVID-19 outbreak will benefit the expansion of the market for insomniac remedies. Due to improperly functioning industries brought on by the COVID-19 pandemic, many workers lost their jobs, which contributed to an increase in stress levels in society. Additionally, some people around the world developed depression as a result of pandemic fear. As a result, the COVID-19 pandemic's increased incidence of insomnia a condition marked by stress and depression boosts the demand for drugs that treat insomnia and propel the market's expansion.

Market Growth Factors

Increasing Aging Population

According to studies, older people (defined as those 65 and older) appear to have an 11-fold increased risk of developing some types of cancer than younger people. The burden of cancer among the elderly would then increase as the world population ages over the following 20 years. Refractive errors, cataracts, sleep issues, and hearing loss are all fairly common in older people. A large ratio of old age people is facing sleeping issues worldwide. Thus, the rise in the aging population would result in an increasing number of insomnia cases which would further support the growth of the insomnia market over the forecast period.

Increasing Healthcare Costs

Rising healthcare costs and earlier disease diagnosis because of greater awareness of treatment options are factors that are anticipated to fuel the market growth over the course of the forecast period. The increasing size and number of funds invested in the healthcare industry by governments of different countries are one of the primary drivers of the market's growth. Governments from a number of nations boosted their investments in creating healthcare systems whenever the COVID-19 pandemic first started to spread. As the pandemic's impact lessens, various hospitals are now concentrating on using these resources to treat other severe diseases. The insomnia market is expanding as a result of rising healthcare investment.

Market Restraining Factors

High Cost Of Diagnosing And Treating Insomnia

The high cost of diagnosis and treatment is one of the major factors impeding the growth of the insomnia market. Additionally, the term "sleeping problem" covers a wide range of illnesses that have significant detrimental effects on an individual's health and incur high societal costs. Insomnia makes it difficult to carry out daily tasks and is associated with a heavy financial & medical burden many patients are completely disabled. Insomnia patients spent about two times as much on direct medical care each year as matched controls without condition. The market for insomnia is not expanding because of the high cost of the medication.

Distribution Channel Outlook

By distribution channel, the insomnia market is divided into hospital, retail and others. The retail segment recorded a substantial revenue share in the insomnia market in 2021. The market in this segment is growing as a result of the wide availability of pills for treatment of sleeping disorder in various retail stores. In addition, the market is also growing due to rising awareness of consequences of diseases such as insomnia. Also, the government is supporting the medicines for condition to be marketed in such stores.

Therapy Type Outlook

Based on therapy type, the insomnia market is segmented into non-pharmacological therapy, pharmacological therapy. In 2021, the pharmacological therapy segment dominated the insomnia market with the maximum revenue share. This is due to the rising prevalence of insomnia and the growing number of major manufacturers of therapeutic drugs for insomnia. The presence of pills for insomnia treatment and sleeping pills is wide all over the world. The market is expanding in this segment as a result of a large number of market players present all over the world.

Regional Outlook

Region wise, the insomnia market is analyzed across the North America, Europe, Asia Pacific and LAMEA. In 2021, the North America region held the highest revenue share in the insomnia market. This is due to an increase in the prevalence of insomnia, a high incidence of stress at work, and a developed healthcare system, including the presence of insomnia centers in the region. Additionally, a rise in the number of patients suffering from chronic renal and kidney illnesses as well as the existence of a sizable number of insomnia clinics in this region are predicted to fuel market growth.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Currax Pharmaceuticals LLC (Currax Holdings USA LLC), Eisai Co., Ltd., Merck Group, Pfizer, Inc., Vanda Pharmaceuticals, Inc., Cadila Healthcare Ltd. (Zydus Cadila), Sanofi S.A., Viatris, Inc., Takeda Pharmaceutical Company Limited, and Purdue Pharma L.P.

Strategies deployed in Insomnia Market

Oct-2021: Currax expanded its geographical footprints in Brentwood by opening HQ in the region. This expansion aimed at expanding access to medicines, both generic and brand name.

Dec-2020: Vanda Pharmaceuticals got FDA approval for the HETLIOZ capsule & liquid formulation, the first FDA-approved medication for patients with SMS. The product would be used for the treatment of adults & children, respectively, with nighttime sleep disturbances associated with Smith-Magenis Syndrome (SMS).

Jun-2020: Sanofi expanded its geographical footprint in India. This expansion focused on producing Amaryl & Daonil tablets for blood glucose reduction, Frisium for seizures, and Stilnoct for insomnia in the region.

Jun-2020: Eisai launched DAYVIGO CIV, the in-house discovered orexin receptor antagonist. This launch would address adults with insomnia, characterized by difficulties with sleep onset and sleep maintenance.

Dec-2019: Eisai got FDA approval for DAYVIGO. Through this approval, DAYVIGO would be commercially available in 5 mg and 10 mg tablets following scheduling by the U.S. Drug Enforcement Administration (DEA), which is expected to occur within 90 days.

Sep-2019: Currax signed an agreement to acquire Nalpropion Pharmaceuticals, a biopharmaceutical company focused on the treatment of weight loss. This acquisition enables Currax to own the worldwide rights to CONTRAVE, one of the most prescribed weight-loss brand medications in the US.

Sep-2019: Takeda and Lundbeck got Labour and Welfare (MHLW) approval of Trintellix. By this approval, Trintellix would be able to provide the treatment of depression and depressed state.

Jul-2019: Zydus Cadila introduced Ramelteon tablets, USFDA-approved capsules used to treat insomnia. Ramelteon would be used in the treatment of insomnia associated with having trouble falling asleep.

Scope of the Study

Market Segments covered in the Report:

By Distribution Channel

  • Hospital
  • Retail
  • Others

By Therapy Type

  • Pharmacological
  • Non-Pharmacological

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
  • Eisai Co., Ltd.
  • Merck Group
  • Pfizer, Inc.
  • Vanda Pharmaceuticals, Inc.
  • Cadila Healthcare Ltd. (Zydus Cadila)
  • Sanofi S.A.
  • Viatris, Inc.
  • Takeda Pharmaceutical Company Limited
  • Purdue Pharma L.P.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Insomnia Market, by Distribution Channel
    • 1.4.2 Global Insomnia Market, by Therapy Type
    • 1.4.3 Global Insomnia Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies deployed in Insomnia Market

Chapter 4. Global Insomnia Market by Distribution Channel

  • 4.1 Global Hospital Market by Region
  • 4.2 Global Retail Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global Insomnia Market by Therapy Type

  • 5.1 Global Pharmacological Market by Region
  • 5.2 Global Non-Pharmacological Market by Region

Chapter 6. Global Insomnia Market by Region

  • 6.1 North America Insomnia Market
    • 6.1.1 North America Insomnia Market by Distribution Channel
      • 6.1.1.1 North America Hospital Market by Country
      • 6.1.1.2 North America Retail Market by Country
      • 6.1.1.3 North America Others Market by Country
    • 6.1.2 North America Insomnia Market by Therapy Type
      • 6.1.2.1 North America Pharmacological Market by Country
      • 6.1.2.2 North America Non-Pharmacological Market by Country
    • 6.1.3 North America Insomnia Market by Country
      • 6.1.3.1 US Insomnia Market
        • 6.1.3.1.1 US Insomnia Market by Distribution Channel
        • 6.1.3.1.2 US Insomnia Market by Therapy Type
      • 6.1.3.2 Canada Insomnia Market
        • 6.1.3.2.1 Canada Insomnia Market by Distribution Channel
        • 6.1.3.2.2 Canada Insomnia Market by Therapy Type
      • 6.1.3.3 Mexico Insomnia Market
        • 6.1.3.3.1 Mexico Insomnia Market by Distribution Channel
        • 6.1.3.3.2 Mexico Insomnia Market by Therapy Type
      • 6.1.3.4 Rest of North America Insomnia Market
        • 6.1.3.4.1 Rest of North America Insomnia Market by Distribution Channel
        • 6.1.3.4.2 Rest of North America Insomnia Market by Therapy Type
  • 6.2 Europe Insomnia Market
    • 6.2.1 Europe Insomnia Market by Distribution Channel
      • 6.2.1.1 Europe Hospital Market by Country
      • 6.2.1.2 Europe Retail Market by Country
      • 6.2.1.3 Europe Others Market by Country
    • 6.2.2 Europe Insomnia Market by Therapy Type
      • 6.2.2.1 Europe Pharmacological Market by Country
      • 6.2.2.2 Europe Non-Pharmacological Market by Country
    • 6.2.3 Europe Insomnia Market by Country
      • 6.2.3.1 Germany Insomnia Market
        • 6.2.3.1.1 Germany Insomnia Market by Distribution Channel
        • 6.2.3.1.2 Germany Insomnia Market by Therapy Type
      • 6.2.3.2 UK Insomnia Market
        • 6.2.3.2.1 UK Insomnia Market by Distribution Channel
        • 6.2.3.2.2 UK Insomnia Market by Therapy Type
      • 6.2.3.3 France Insomnia Market
        • 6.2.3.3.1 France Insomnia Market by Distribution Channel
        • 6.2.3.3.2 France Insomnia Market by Therapy Type
      • 6.2.3.4 Russia Insomnia Market
        • 6.2.3.4.1 Russia Insomnia Market by Distribution Channel
        • 6.2.3.4.2 Russia Insomnia Market by Therapy Type
      • 6.2.3.5 Spain Insomnia Market
        • 6.2.3.5.1 Spain Insomnia Market by Distribution Channel
        • 6.2.3.5.2 Spain Insomnia Market by Therapy Type
      • 6.2.3.6 Italy Insomnia Market
        • 6.2.3.6.1 Italy Insomnia Market by Distribution Channel
        • 6.2.3.6.2 Italy Insomnia Market by Therapy Type
      • 6.2.3.7 Rest of Europe Insomnia Market
        • 6.2.3.7.1 Rest of Europe Insomnia Market by Distribution Channel
        • 6.2.3.7.2 Rest of Europe Insomnia Market by Therapy Type
  • 6.3 Asia Pacific Insomnia Market
    • 6.3.1 Asia Pacific Insomnia Market by Distribution Channel
      • 6.3.1.1 Asia Pacific Hospital Market by Country
      • 6.3.1.2 Asia Pacific Retail Market by Country
      • 6.3.1.3 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Insomnia Market by Therapy Type
      • 6.3.2.1 Asia Pacific Pharmacological Market by Country
      • 6.3.2.2 Asia Pacific Non-Pharmacological Market by Country
    • 6.3.3 Asia Pacific Insomnia Market by Country
      • 6.3.3.1 China Insomnia Market
        • 6.3.3.1.1 China Insomnia Market by Distribution Channel
        • 6.3.3.1.2 China Insomnia Market by Therapy Type
      • 6.3.3.2 Japan Insomnia Market
        • 6.3.3.2.1 Japan Insomnia Market by Distribution Channel
        • 6.3.3.2.2 Japan Insomnia Market by Therapy Type
      • 6.3.3.3 India Insomnia Market
        • 6.3.3.3.1 India Insomnia Market by Distribution Channel
        • 6.3.3.3.2 India Insomnia Market by Therapy Type
      • 6.3.3.4 South Korea Insomnia Market
        • 6.3.3.4.1 South Korea Insomnia Market by Distribution Channel
        • 6.3.3.4.2 South Korea Insomnia Market by Therapy Type
      • 6.3.3.5 Singapore Insomnia Market
        • 6.3.3.5.1 Singapore Insomnia Market by Distribution Channel
        • 6.3.3.5.2 Singapore Insomnia Market by Therapy Type
      • 6.3.3.6 Malaysia Insomnia Market
        • 6.3.3.6.1 Malaysia Insomnia Market by Distribution Channel
        • 6.3.3.6.2 Malaysia Insomnia Market by Therapy Type
      • 6.3.3.7 Rest of Asia Pacific Insomnia Market
        • 6.3.3.7.1 Rest of Asia Pacific Insomnia Market by Distribution Channel
        • 6.3.3.7.2 Rest of Asia Pacific Insomnia Market by Therapy Type
  • 6.4 LAMEA Insomnia Market
    • 6.4.1 LAMEA Insomnia Market by Distribution Channel
      • 6.4.1.1 LAMEA Hospital Market by Country
      • 6.4.1.2 LAMEA Retail Market by Country
      • 6.4.1.3 LAMEA Others Market by Country
    • 6.4.2 LAMEA Insomnia Market by Therapy Type
      • 6.4.2.1 LAMEA Pharmacological Market by Country
      • 6.4.2.2 LAMEA Non-Pharmacological Market by Country
    • 6.4.3 LAMEA Insomnia Market by Country
      • 6.4.3.1 Brazil Insomnia Market
        • 6.4.3.1.1 Brazil Insomnia Market by Distribution Channel
        • 6.4.3.1.2 Brazil Insomnia Market by Therapy Type
      • 6.4.3.2 Argentina Insomnia Market
        • 6.4.3.2.1 Argentina Insomnia Market by Distribution Channel
        • 6.4.3.2.2 Argentina Insomnia Market by Therapy Type
      • 6.4.3.3 UAE Insomnia Market
        • 6.4.3.3.1 UAE Insomnia Market by Distribution Channel
        • 6.4.3.3.2 UAE Insomnia Market by Therapy Type
      • 6.4.3.4 Saudi Arabia Insomnia Market
        • 6.4.3.4.1 Saudi Arabia Insomnia Market by Distribution Channel
        • 6.4.3.4.2 Saudi Arabia Insomnia Market by Therapy Type
      • 6.4.3.5 South Africa Insomnia Market
        • 6.4.3.5.1 South Africa Insomnia Market by Distribution Channel
        • 6.4.3.5.2 South Africa Insomnia Market by Therapy Type
      • 6.4.3.6 Nigeria Insomnia Market
        • 6.4.3.6.1 Nigeria Insomnia Market by Distribution Channel
        • 6.4.3.6.2 Nigeria Insomnia Market by Therapy Type
      • 6.4.3.7 Rest of LAMEA Insomnia Market
        • 6.4.3.7.1 Rest of LAMEA Insomnia Market by Distribution Channel
        • 6.4.3.7.2 Rest of LAMEA Insomnia Market by Therapy Type

Chapter 7. Company Profiles

  • 7.1 Eisai Co., Ltd.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expenses
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Product Launches and Product Expansions:
      • 7.1.5.2 Approvals and Trails:
  • 7.2 Takeda Pharmaceutical Company Limited
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Approvals and Trails:
  • 7.3 Vanda Pharmaceuticals, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Research & Development Expenses
    • 7.3.4 Recent strategies and developments:
      • 7.3.4.1 Approval and Trails:
  • 7.4 Cadila Healthcare Ltd. (Zydus Cadila)
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Product Launches and Product Expansions:
  • 7.5 Sanofi S.A.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Geographical Expansions:
  • 7.6 Merck Group
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
  • 7.7 Pfizer, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Regional & Segmental Analysis
    • 7.7.4 Research & Development Expense
  • 7.8 Viatris, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
  • 7.9 Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
    • 7.9.1 Company Overview
    • 7.9.2 Recent strategies and developments:
      • 7.9.2.1 Acquisition and Mergers:
      • 7.9.2.2 Geographical Expansions:
  • 7.10. Purdue Pharma L.P.
    • 7.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Insomnia Market, 2018 - 2021, USD Million
  • TABLE 2 Global Insomnia Market, 2022 - 2028, USD Million
  • TABLE 3 Global Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 4 Global Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 5 Global Hospital Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Hospital Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Retail Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Retail Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 12 Global Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 13 Global Pharmacological Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Pharmacological Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Non-Pharmacological Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Non-Pharmacological Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Insomnia Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Insomnia Market by Region, 2022 - 2028, USD Million
  • TABLE 19 North America Insomnia Market, 2018 - 2021, USD Million
  • TABLE 20 North America Insomnia Market, 2022 - 2028, USD Million
  • TABLE 21 North America Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 22 North America Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 23 North America Hospital Market by Country, 2018 - 2021, USD Million
  • TABLE 24 North America Hospital Market by Country, 2022 - 2028, USD Million
  • TABLE 25 North America Retail Market by Country, 2018 - 2021, USD Million
  • TABLE 26 North America Retail Market by Country, 2022 - 2028, USD Million
  • TABLE 27 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 28 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 29 North America Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 30 North America Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 31 North America Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 32 North America Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 33 North America Non-Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Non-Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Insomnia Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Insomnia Market by Country, 2022 - 2028, USD Million
  • TABLE 37 US Insomnia Market, 2018 - 2021, USD Million
  • TABLE 38 US Insomnia Market, 2022 - 2028, USD Million
  • TABLE 39 US Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 40 US Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 41 US Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 42 US Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 43 Canada Insomnia Market, 2018 - 2021, USD Million
  • TABLE 44 Canada Insomnia Market, 2022 - 2028, USD Million
  • TABLE 45 Canada Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 46 Canada Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 47 Canada Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 48 Canada Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 49 Mexico Insomnia Market, 2018 - 2021, USD Million
  • TABLE 50 Mexico Insomnia Market, 2022 - 2028, USD Million
  • TABLE 51 Mexico Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 52 Mexico Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 53 Mexico Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 54 Mexico Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 55 Rest of North America Insomnia Market, 2018 - 2021, USD Million
  • TABLE 56 Rest of North America Insomnia Market, 2022 - 2028, USD Million
  • TABLE 57 Rest of North America Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 58 Rest of North America Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 59 Rest of North America Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 60 Rest of North America Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 61 Europe Insomnia Market, 2018 - 2021, USD Million
  • TABLE 62 Europe Insomnia Market, 2022 - 2028, USD Million
  • TABLE 63 Europe Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 64 Europe Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 65 Europe Hospital Market by Country, 2018 - 2021, USD Million
  • TABLE 66 Europe Hospital Market by Country, 2022 - 2028, USD Million
  • TABLE 67 Europe Retail Market by Country, 2018 - 2021, USD Million
  • TABLE 68 Europe Retail Market by Country, 2022 - 2028, USD Million
  • TABLE 69 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 70 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 71 Europe Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 72 Europe Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 73 Europe Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 74 Europe Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 75 Europe Non-Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 76 Europe Non-Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 77 Europe Insomnia Market by Country, 2018 - 2021, USD Million
  • TABLE 78 Europe Insomnia Market by Country, 2022 - 2028, USD Million
  • TABLE 79 Germany Insomnia Market, 2018 - 2021, USD Million
  • TABLE 80 Germany Insomnia Market, 2022 - 2028, USD Million
  • TABLE 81 Germany Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 82 Germany Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 83 Germany Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 84 Germany Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 85 UK Insomnia Market, 2018 - 2021, USD Million
  • TABLE 86 UK Insomnia Market, 2022 - 2028, USD Million
  • TABLE 87 UK Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 88 UK Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 89 UK Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 90 UK Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 91 France Insomnia Market, 2018 - 2021, USD Million
  • TABLE 92 France Insomnia Market, 2022 - 2028, USD Million
  • TABLE 93 France Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 94 France Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 95 France Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 96 France Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 97 Russia Insomnia Market, 2018 - 2021, USD Million
  • TABLE 98 Russia Insomnia Market, 2022 - 2028, USD Million
  • TABLE 99 Russia Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 100 Russia Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 101 Russia Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 102 Russia Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 103 Spain Insomnia Market, 2018 - 2021, USD Million
  • TABLE 104 Spain Insomnia Market, 2022 - 2028, USD Million
  • TABLE 105 Spain Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 106 Spain Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 107 Spain Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 108 Spain Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 109 Italy Insomnia Market, 2018 - 2021, USD Million
  • TABLE 110 Italy Insomnia Market, 2022 - 2028, USD Million
  • TABLE 111 Italy Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 112 Italy Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 113 Italy Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 114 Italy Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 115 Rest of Europe Insomnia Market, 2018 - 2021, USD Million
  • TABLE 116 Rest of Europe Insomnia Market, 2022 - 2028, USD Million
  • TABLE 117 Rest of Europe Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 118 Rest of Europe Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 119 Rest of Europe Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 120 Rest of Europe Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 121 Asia Pacific Insomnia Market, 2018 - 2021, USD Million
  • TABLE 122 Asia Pacific Insomnia Market, 2022 - 2028, USD Million
  • TABLE 123 Asia Pacific Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 124 Asia Pacific Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 125 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Million
  • TABLE 126 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Million
  • TABLE 127 Asia Pacific Retail Market by Country, 2018 - 2021, USD Million
  • TABLE 128 Asia Pacific Retail Market by Country, 2022 - 2028, USD Million
  • TABLE 129 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 130 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 131 Asia Pacific Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 132 Asia Pacific Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 133 Asia Pacific Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 134 Asia Pacific Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 135 Asia Pacific Non-Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 136 Asia Pacific Non-Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 137 Asia Pacific Insomnia Market by Country, 2018 - 2021, USD Million
  • TABLE 138 Asia Pacific Insomnia Market by Country, 2022 - 2028, USD Million
  • TABLE 139 China Insomnia Market, 2018 - 2021, USD Million
  • TABLE 140 China Insomnia Market, 2022 - 2028, USD Million
  • TABLE 141 China Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 142 China Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 143 China Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 144 China Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 145 Japan Insomnia Market, 2018 - 2021, USD Million
  • TABLE 146 Japan Insomnia Market, 2022 - 2028, USD Million
  • TABLE 147 Japan Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 148 Japan Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 149 Japan Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 150 Japan Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 151 India Insomnia Market, 2018 - 2021, USD Million
  • TABLE 152 India Insomnia Market, 2022 - 2028, USD Million
  • TABLE 153 India Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 154 India Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 155 India Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 156 India Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 157 South Korea Insomnia Market, 2018 - 2021, USD Million
  • TABLE 158 South Korea Insomnia Market, 2022 - 2028, USD Million
  • TABLE 159 South Korea Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 160 South Korea Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 161 South Korea Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 162 South Korea Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 163 Singapore Insomnia Market, 2018 - 2021, USD Million
  • TABLE 164 Singapore Insomnia Market, 2022 - 2028, USD Million
  • TABLE 165 Singapore Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 166 Singapore Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 167 Singapore Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 168 Singapore Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 169 Malaysia Insomnia Market, 2018 - 2021, USD Million
  • TABLE 170 Malaysia Insomnia Market, 2022 - 2028, USD Million
  • TABLE 171 Malaysia Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 172 Malaysia Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 173 Malaysia Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 174 Malaysia Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 175 Rest of Asia Pacific Insomnia Market, 2018 - 2021, USD Million
  • TABLE 176 Rest of Asia Pacific Insomnia Market, 2022 - 2028, USD Million
  • TABLE 177 Rest of Asia Pacific Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 178 Rest of Asia Pacific Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 179 Rest of Asia Pacific Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 180 Rest of Asia Pacific Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 181 LAMEA Insomnia Market, 2018 - 2021, USD Million
  • TABLE 182 LAMEA Insomnia Market, 2022 - 2028, USD Million
  • TABLE 183 LAMEA Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 184 LAMEA Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 185 LAMEA Hospital Market by Country, 2018 - 2021, USD Million
  • TABLE 186 LAMEA Hospital Market by Country, 2022 - 2028, USD Million
  • TABLE 187 LAMEA Retail Market by Country, 2018 - 2021, USD Million
  • TABLE 188 LAMEA Retail Market by Country, 2022 - 2028, USD Million
  • TABLE 189 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 190 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 191 LAMEA Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 192 LAMEA Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 193 LAMEA Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 194 LAMEA Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 195 LAMEA Non-Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 196 LAMEA Non-Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 197 LAMEA Insomnia Market by Country, 2018 - 2021, USD Million
  • TABLE 198 LAMEA Insomnia Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Brazil Insomnia Market, 2018 - 2021, USD Million
  • TABLE 200 Brazil Insomnia Market, 2022 - 2028, USD Million
  • TABLE 201 Brazil Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 202 Brazil Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 203 Brazil Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 204 Brazil Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 205 Argentina Insomnia Market, 2018 - 2021, USD Million
  • TABLE 206 Argentina Insomnia Market, 2022 - 2028, USD Million
  • TABLE 207 Argentina Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 208 Argentina Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 209 Argentina Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 210 Argentina Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 211 UAE Insomnia Market, 2018 - 2021, USD Million
  • TABLE 212 UAE Insomnia Market, 2022 - 2028, USD Million
  • TABLE 213 UAE Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 214 UAE Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 215 UAE Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 216 UAE Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 217 Saudi Arabia Insomnia Market, 2018 - 2021, USD Million
  • TABLE 218 Saudi Arabia Insomnia Market, 2022 - 2028, USD Million
  • TABLE 219 Saudi Arabia Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 220 Saudi Arabia Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 221 Saudi Arabia Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 222 Saudi Arabia Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 223 South Africa Insomnia Market, 2018 - 2021, USD Million
  • TABLE 224 South Africa Insomnia Market, 2022 - 2028, USD Million
  • TABLE 225 South Africa Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 226 South Africa Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 227 South Africa Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 228 South Africa Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 229 Nigeria Insomnia Market, 2018 - 2021, USD Million
  • TABLE 230 Nigeria Insomnia Market, 2022 - 2028, USD Million
  • TABLE 231 Nigeria Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 232 Nigeria Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 233 Nigeria Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 234 Nigeria Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 235 Rest of LAMEA Insomnia Market, 2018 - 2021, USD Million
  • TABLE 236 Rest of LAMEA Insomnia Market, 2022 - 2028, USD Million
  • TABLE 237 Rest of LAMEA Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 238 Rest of LAMEA Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 239 Rest of LAMEA Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 240 Rest of LAMEA Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 241 Key Information - Eisai Co., Ltd.
  • TABLE 242 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 243 Key Information - Vanda Pharmaceuticals, Inc.
  • TABLE 244 Key Information - Cadila Healthcare Ltd.
  • TABLE 245 Key Information - Sanofi S.A.
  • TABLE 246 key Information - Merck GrouP
  • TABLE 247 Key Information - Pfizer, Inc.
  • TABLE 248 key information - Viatris, Inc.
  • TABLE 249 Key Information - Currax Pharmaceuticals LLC
  • TABLE 250 Key Information - Purdue Pharma L.P.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Insomnia Market share by Distribution Channel, 2021
  • FIG 3 Global Insomnia Market share by Distribution Channel, 2028
  • FIG 4 Global Insomnia Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 5 Global Insomnia Market share by Therapy Type, 2021
  • FIG 6 Global Insomnia Market share by Therapy Type, 2028
  • FIG 7 Global Insomnia Market by Therapy Type, 2018 - 2028, USD Million
  • FIG 8 Global Insomnia Market share by Region, 2021
  • FIG 9 Global Insomnia Market share by Region, 2028
  • FIG 10 Global Insomnia Market by Region, 2018 - 2028, USD Million
  • FIG 11 Recent strategies and developments: Eisai Co., Ltd.
  • FIG 12 Recent strategies and developments: Currax Pharmaceuticals LLC